scispace - formally typeset
R

Roberto Romero

Researcher at National Institutes of Health

Publications -  1622
Citations -  121818

Roberto Romero is an academic researcher from National Institutes of Health. The author has contributed to research in topics: Amniotic fluid & Pregnancy. The author has an hindex of 151, co-authored 1516 publications receiving 108321 citations. Previous affiliations of Roberto Romero include University of Michigan & Weizmann Institute of Science.

Papers
More filters
Journal Article

Infection of the amniotic cavity with Ureaplasma urealyticum in the midtrimester of pregnancy.

TL;DR: It is concluded that infection of the amniotic cavity with U urealyticum can be present in asymptomatic patients in the midtrimester of pregnancy and is a significant risk factor for spontaneous preterm labor and delivery.
Journal ArticleDOI

Late-onset preeclampsia is associated with an imbalance of angiogenic and anti-angiogenic factors in patients with and without placental lesions consistent with maternal underperfusion

TL;DR: Nearly half of the patients with late-onset PE have placental lesions consistent with maternal underperfusion, which are associated with an imbalance in the maternal concentration of angiogenic/anti-angiogenic factors.
Journal ArticleDOI

The tumor necrosis factor α and its soluble receptor profile in term and preterm parturition

TL;DR: Observations provide support for the thesis that preterm parturition is a pathologic condition and increased tumor necrosis factor α soluble receptor concentrations may attenuate the deleterious effects of the excess of tumor necrot factor α found in pathologic labor.
Journal ArticleDOI

An elevated amniotic fluid matrix metalloproteinase-8 level at the time of mid-trimester genetic amniocentesis is a risk factor for spontaneous preterm delivery.

TL;DR: Elevated mid-trimester concentrations of amniotic fluid matrix metalloproteinase-8, and cytokines such as interleukin-6 and angiogenin can identify patients at risk for spontaneous preterm delivery in patients undergoing mid- Trimester amniocentesis.